Socrates Herrera
Overview
Explore the profile of Socrates Herrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
3131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lima-Cordon R, Mohabir J, Sooklall M, Zurita A, Shieh M, Knox C, et al.
Mol Ecol Resour
. 2025 Feb;
:e14088.
PMID: 39963041
Vector control remains an important strategy worldwide to prevent human infection with pathogens transmitted by arthropods. Vector control strategies rely on accurate identification of vector taxa along with vector-specific biological...
2.
Rojas-Pena M, Duan M, Arafat D, Rengifo L, Herrera S, Arevalo-Herrera M, et al.
J Pers Med
. 2024 Oct;
14(10).
PMID: 39452575
In the original publication [...].
3.
Balam S, Miura K, Ayadi I, Konate D, Incandela N, Agnolon V, et al.
bioRxiv
. 2024 Apr;
PMID: 38659832
Background: 48/45, a gametocyte surface protein, is a promising candidate for malaria transmission-blocking (TB) vaccine. Due to its relevance for a multispecies vaccine, we explored the cross-reactivity and TB activity...
4.
Lopez-Perez M, Jain A, Davies D, Vasquez-Jimenez J, Herrera S, Onate J, et al.
Sci Rep
. 2024 Feb;
14(1):2790.
PMID: 38307966
Malaria sterile immunity has been reproducibly induced by immunization with Plasmodium radiation-attenuated sporozoites (RAS). Analyses of sera from RAS-immunized individuals allowed the identification of P. falciparum antigens, such as the...
5.
Sutanto E, Pava Z, Echeverry D, Lopera-Mesa T, Montenegro L, Yasnot-Acosta M, et al.
Sci Rep
. 2023 Nov;
13(1):19779.
PMID: 37957271
Colombia aims to eliminate malaria by 2030 but remains one of the highest burden countries in the Americas. Plasmodium vivax contributes half of all malaria cases, with its control challenged...
6.
Florimond C, de Laval F, Early A, Sauthier S, Lazrek Y, Pelleau S, et al.
Lancet Infect Dis
. 2023 Oct;
24(2):161-171.
PMID: 37858325
Background: Plasmodium falciparum is an apicomplexan parasite responsible for lethal cases of malaria. According to WHO recommendations, P falciparum cases are treated with artemisinin-based combination therapy including dihydroartemisinin-piperaquine. However, the...
7.
Forero-Pena D, Carrion-Nessi F, Lopez-Perez M, Mora M, Amaya I, Gamardo A, et al.
Infect Dis Poverty
. 2023 Apr;
12(1):33.
PMID: 37038195
Background: Malaria remains a leading public health problem worldwide. Co-infections with other pathogens complicate its diagnosis and may modify the disease's clinical course and management. Similarities in malaria clinical presentation...
8.
Pratesi F, Errante F, Pacini L, Pena-Moreno I, Quiceno S, Carotenuto A, et al.
Front Immunol
. 2022 Jun;
13:879946.
PMID: 35693806
The currently devastating pandemic of severe acute respiratory syndrome known as coronavirus disease 2019 or COVID-19 is caused by the coronavirus SARS-CoV-2. Both the virus and the disease have been...
9.
Traore A, Guindo M, Konate D, Traore B, Diakite S, Kante S, et al.
Front Immunol
. 2022 May;
13:856033.
PMID: 35585976
Despite the global interest and the unprecedented number of scientific studies triggered by the COVID-19 pandemic, few data are available from developing and low-income countries. In these regions, communities live...
10.
Arevalo-Herrera M, Gaitan X, Larmat-Delgado M, Caicedo M, Herrera S, Henao-Giraldo J, et al.
Nat Commun
. 2022 Mar;
13(1):1603.
PMID: 35338131
A randomized, double-blind, controlled vaccine clinical trial was conducted to assess, as the primary outcome, the safety and protective efficacy of the Plasmodium vivax circumsporozoite (CS) protein in healthy malaria-naïve...